17-65852034-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001199165.4(CEP112):c.2164G>T(p.Val722Phe) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000251 in 1,595,856 control chromosomes in the GnomAD database, with no homozygous occurrence. 2/3 splice prediction tools predicting alterations to normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001199165.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEP112 | NM_001199165.4 | c.2164G>T | p.Val722Phe | missense_variant, splice_region_variant | 21/27 | ENST00000535342.7 | NP_001186094.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEP112 | ENST00000535342.7 | c.2164G>T | p.Val722Phe | missense_variant, splice_region_variant | 21/27 | 2 | NM_001199165.4 | ENSP00000442784.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152128Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000426 AC: 1AN: 234882Hom.: 0 AF XY: 0.00000787 AC XY: 1AN XY: 127038
GnomAD4 exome AF: 0.00000208 AC: 3AN: 1443728Hom.: 0 Cov.: 30 AF XY: 0.00000139 AC XY: 1AN XY: 717690
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152128Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 11, 2024 | The c.2164G>T (p.V722F) alteration is located in exon 21 (coding exon 20) of the CEP112 gene. This alteration results from a G to T substitution at nucleotide position 2164, causing the valine (V) at amino acid position 722 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at